login
Password reminder
Interventional News
Contact the editor Visit Interventional News Twitter feed Visit Interventional News Facebook page
 

First successful below-the-knee procedures with the Proteus device performed in the USA


Friday, 13 Jul 2012 13:47
Proteus
Proteus

Angioslide, a provider of embolic capture angioplasty solutions, has announced the successful deployment of a 3X100mm Proteus device for treating peripheral artery disease in below-the-knee (BTK) vasculature at Community Hospital in Munster, USA. Accommodating a 0.014” guide-wire, the new device allows physician to perform a PTA revascularisation in BTK vessels while capturing and removing embolic particles. 


“With Proteus having been successfully used to treat lesions in the SFA (superficial femoral artery), I had the opportunity to deploy the device in BTK procedures,” said Prakash Makam, Community Hospital. “It is an effective, easy to use tool that provides an alternative for removal of embolic material, including micro particles, that could compromise downstream vasculature flow and perfusion to the foot. This is especially important when treating high-risk, diabetic and critical limb ischaemia patients.”

Angioslide’s proprietary technology combines the functionality of a balloon angioplasty device with the addition of capture and removal of particles released during intervention. Capture of embolic material is enabled by the inward folding of the balloon through a dedicated handle, which creates a suction effect that pulls embolic material into the cavity. When retrieved through the sheath, Proteus removes the captured material from the body.


“We are excited to provide a solution for capture and removal of embolic debris for below-the-knee intervention, where the clinical consequences of emboli are amplified by small vessel diameter,” said Lihu Avitov, CEO, Angioslide. “The current set of tools available on the market for BTK intervention are suboptimal, and we look forward to meeting this important clinical need. With the successful completion of our first cases in the USA, we will introduce our product to a wider number of centers.”


According to a company release, the Proteus is the first device of its kind to receive FDA clearance for use in lower limbs (the femoral, iliac, ilio-femoral, popliteal, tibial, peroneal, and profunda arteries). The device has also received European CE mark approval for lower limb use and is being marketed in selected regions in Europe.




Add New Comment

Related Items


Most popular


First implant completed in thoracoabdominal aortic aneurysm clinical study
Wednesday, 13 Jan 2016
The first US implant of the Gore Excluder thoracoabdominal branch endoprosthesis has taken place during a clinical study of the treatment of aortic aneurysms involving the visceral branch vessels. First implant completed in thoracoabdominal aortic aneurysm clinical study

Systematic review of registry data suggests stroke or death rate after carotid stenting “significantly higher” than after endarterectomy
Monday, 18 Jan 2016
The review, published in the January 2016 issue of the European Journal of Vascular and Endovascular Surgery (EJVES), further concludes that stroke/death rates after carotid stenting often exceed ... Systematic review of registry data suggests stroke or death rate after carotid stenting “significantly higher” than after endarterectomy

Medtronic launches OsteoCool radiofrequency ablation system in the US
Wednesday, 13 Jan 2016
The OsteoCool radiofrequency ablation system is designed to treat patients with painful spinal metastases. The system has been granted US Food and Drug Administration (FDA) 510(k) marketing clearance. Medtronic launches OsteoCool radiofrequency ablation system in the US

Features


Interventional radiology in trauma management
Friday, 05 Feb 2016
The role of interventional radiology in the management of severely traumatised patients began three to four decades ago with the embolization of the internal iliac arteries for massive pelvic ... Interventional radiology in trauma management

Microvascular plugs investigated in embolization of pulmonary arteriovenous malformations
Monday, 30 Nov 2015
Miles Conrad, University of California San Francisco (UCSF), Interventional Radiology section and co-director of the UCSF HHT Centre of Excellence, spoke to Interventional News about a new device ... Microvascular plugs investigated in embolization of pulmonary arteriovenous malformations

Profiles


Gabriel Bartal
Thursday, 26 Nov 2015
“In the early days, I used to have to cut a 7F plastic tube, make side holes, send it off for ... Gabriel Bartal

Lindsay Machan
Thursday, 28 May 2015
“Focusing on maximising rewards has sidelined more ideas than it has helped individual inventors. S... Lindsay Machan

Cardiac Rhythm News Vascular News Cardiovascular News Interventional News Spinal News NeuroNews
BIBA Medical BIBA MedTech Insights CX Symposium ilegx
Password Reminder

BIBA Medical, 526 Fulham Road, Fulham, London, SW6 5NR.
TEL: +44 (0)20 7736 8788 FAX: +44 (0)20 7736 8283 EMAIL: 
info@bibamedical.com
© BIBA Medical Ltd is a company registered in England and Wales with company number 2944429.
VAT registration number 730 6811 50.
Site Map | Terms and Conditions